78. Hypopituitarism Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 492 Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100

Drugs and their primary sponsors and trial info
ACP-001   
   ASCENDIS PHARMA A/S
      2010   -   EUCTR2010-021523-28-IT   Austria;Denmark;Germany;Italy;Sweden;
   Ascendis Pharma A/S
      2013   Phase 2   NCT01947907   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-SI   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-GR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-DE   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-CZ   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-HU   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-BG   Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2010   -   EUCTR2010-021523-28-SE   Austria;Denmark;Germany;Italy;Sweden;
      2010   -   EUCTR2010-021523-28-DK   Austria;Denmark;Germany;Italy;Sweden;
      2010   -   EUCTR2010-021523-28-DE   Austria;Denmark;Germany;Italy;Sweden;
      2010   -   EUCTR2010-021523-28-AT   Austria;Denmark;Germany;Italy;Sweden;
      -   Phase 2   EUCTR2012-002787-27-FR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
ACP-001 (TransCon hGH)   
   Ascendis Pharma A/S
      2010   Phase 2   NCT01247675   Denmark;Germany;Italy;Sweden;
ACP-011   
   Ascendis Pharma Endocrinology Division A/S
      2022   Phase 3   EUCTR2020-000929-42-BG   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-IT   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-ES   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
AEZS-130   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-002337-22-IT   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
   Aeterna Zentaris GmbH
      2021   Phase 3   EUCTR2018-001989-42-PL   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
      2016   Phase 3   EUCTR2015-002337-22-PL   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-002337-22-DE   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-002337-22-GB   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-002337-22-AT   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
      -   Phase 3   EUCTR2018-001989-42-DE   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
AEZS-130 (formerly ARD-07)   
   AEterna Zentaris
      2007   Phase 3   NCT00448747   United States;
AGUA PARA PREPARACIONES INYECTABLES   
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-ES   Finland;Spain;Sweden;United Kingdom;
ALRN-5281   
   Aileron Therapeutics
      2013   Phase 1   NCT01775358   United States;
ALTU-238   
   Altus Pharmaceuticals
      2005   Phase 2   NCT00297713   United States;
ARGININA CLORIDRATO   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
ARX201   
   Ambrx, Inc.
      2008   Phase 2   NCT00778518   Hungary;
   Ambrx, Inc., USA
      2008   -   EUCTR2007-001746-40-HU   Hungary;
Acipimox   
   University of Aarhus
      2016   -   NCT02782208   Denmark;
      2012   -   NCT01209416   Denmark;
Albutropin   
   Teva Pharmaceutical Industries Ltd.
      2016   -   EUCTR2014-003796-32-PL   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
      2016   -   EUCTR2014-002736-13-PL   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-SI   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-HR   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-GR   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-DE   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-CZ   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-AT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SI   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HU   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-GR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-DE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-CZ   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-AT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-SK   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-RO   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-LT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-IT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-HU   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-ES   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-BG   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-SK   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-LT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-IT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-ES   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2013   Phase 2   EUCTR2012-004975-37-DE   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SK   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SI   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-SE   Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-HU   Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-GR   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-CZ   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
   Teva Pharmaceutical Industries, Ltd.
      2015   Phase 2   EUCTR2013-004468-69-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   Phase 2   EUCTR2013-004468-69-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   -   EUCTR2013-004468-69-ES   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-HU   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-GR   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
      -   Phase 2   EUCTR2013-004468-69-RO   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Amitriptyline, fluoxetine and tramadol alone (control group)   
   Centro Medico Teknon
      2004   Phase 2   NCT00497562   Spain;
Arg   
   Merck KGaA
      2004   Phase 3   NCT01060488   France;
Arginin   
   Top Institute Food and Nutrition
      -   -   EUCTR2010-018781-23-NL   Netherlands;
Arginine   
   AEterna Zentaris
      2021   Phase 3   NCT04786873   United States;
   Helsinki University Central Hospital
      2001   -   NCT03018886   Finland;
   Osaka City University Graduate School of Medicine
      2017   -   JPRN-UMIN000027260   Japan;
Arginine and Clonidine Stimulation Testing   
   The University of Texas Health Science Center at San Antonio
      2001   Phase 3   NCT00134420   United States;
Arginine stimulation test after each limb   
   Christie Hospital NHS Foundation Trust
      2004   -   NCT00468624   United Kingdom;
Aricept   
   Ludwig Boltzmann Gesellschaft
      2006   -   EUCTR2005-001315-22-AT   Austria;
Arimidex   
   Nemours Children's Clinic
      -   -   EUCTR2012-001183-30-Outside-EU/EEA   United States;
Arimidex (Anastrozole)   
   Nemours Children's Clinic
      2001   Phase 2/Phase 3   NCT00133354   United States;
Audiological and ear, nose and throat examination   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
BPLG-003   
   BioPartners GmbH
      2003   Phase 2/Phase 3   NCT00600808   -
Behavior and neuropsychometric evaluations   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Biopsy   
   University Hospital, Toulouse
      2009   Phase 4   NCT01298180   France;
Blood draws   
   Columbia University
      2007   -   NCT00720902   United States;
Blood sampling before   
   Christie Hospital NHS Foundation Trust
      2004   -   NCT00468624   United Kingdom;
Byetta   
   Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
      2021   Phase 2   EUCTR2020-004115-27-ES   Spain;
CLONIDINA CLORIDRATO   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
CLONIDINE HYDROCHLORIDE   
   Top Institute Food and Nutrition
      -   -   EUCTR2010-018781-23-NL   Netherlands;
Carotid ultrasound   
   Columbia University
      2007   -   NCT00720902   United States;
Catapresan   
   Centre for Human Drug Research
      2007   -   EUCTR2006-003678-82-NL   Netherlands;
Catapresan 75   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
   Aeterna Zentaris GmbH
      2021   Phase 3   EUCTR2018-001989-42-PL   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
      -   Phase 3   EUCTR2018-001989-42-DE   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
Change in daily dosage of Growth Hormone   
   VU University Medical Center
      2013   Phase 4   NCT01877512   Netherlands;
Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001)   
   Hanmi Pharmaceutical Co., Ltd.
      2014   -   EUCTR2011-001826-61-BG   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2012   -   EUCTR2011-001826-61-PL   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2011   -   EUCTR2011-001826-61-HU   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
CinnaTropin®   
   Cinnagen
      2016   Phase 3   NCT03223025   -
Clonidin   
   Top Institute Food and Nutrition
      -   -   EUCTR2010-018781-23-NL   Netherlands;
Clonidine   
   AEterna Zentaris
      2021   Phase 3   NCT04786873   United States;
Clonidine HCl CF 0,150 mg, tabletten   
   Top Institute Food and Nutrition
      -   -   EUCTR2010-018781-23-NL   Netherlands;
Corticotropin   
   Max-Planck-Institute of Psychiatry
      2008   -   NCT00666068   Germany;
DEXA, blood tests, H.G.P.O, osseous age.   
   University Hospital, Toulouse
      2009   Phase 4   NCT01298180   France;
DGH   
   Teva Branded Pharmaceutical Products R&D, Inc.
      2015   Phase 3   NCT02410356   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Daily hGH   
   Visen Pharmaceuticals (Shanghai) Co., Ltd.
      2019   Phase 3   NCT04326374   China;
Daily rhGH   
   Versartis Inc.
      2015   Phase 3   NCT02339090   Belgium;Canada;Netherlands;Poland;Sweden;United States;
Dental evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Determination of growth hormone status   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Dextromethorphan and Caffeine   
   University of Louisville
      2001   -   NCT00458991   United States;
Donepezil   
   Ludwig Boltzmann Gesellschaft
      2006   -   EUCTR2005-001315-22-AT   Austria;
Dose-Establishing Study 1 Niacin   
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2011   Phase 1/Phase 2   NCT01237041   United States;
Dose-Establishing Study 2 Niacin   
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2011   Phase 1/Phase 2   NCT01237041   United States;
Dysmorphology evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Ecombinanat DNA-derived human growth h   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Emcitate   
   Rare Thyroid Therapeutics International
      2020   Phase 2   EUCTR2019-003370-35-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;United Kingdom;United States;
   Rare Thyroid Therapeutics International AB
      2020   Phase 2   EUCTR2019-003370-35-GB   Czech Republic;France;Germany;Italy;Netherlands;United Kingdom;United States;
Endothelial cell biopsy   
   Columbia University
      2007   -   NCT00720902   United States;
Eutropin   
   Daewoong Pharmaceutical Co. LTD.
      2003   Phase 3   NCT02693522   Korea, Republic of;
Experimental: CRH administration   
   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      2021   Phase 4   NCT04902235   Spain;
Experimental: GLP1-RA (exenatide) administration   
   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      2021   Phase 4   NCT04897802   Spain;
Experimental: VRS-317   
   Versartis Inc.
      2012   Phase 1/Phase 2   NCT01718041   United States;
Fat diet   
   University Hospital Inselspital, Berne
      2011   -   NCT01467193   Switzerland;
GENOTROPIN 12 mg powder and solvent for solution for injection.   
   Ascendis Pharma Endocrinology Division A/S
      2018   Phase 3   EUCTR2016-001145-11-DE   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-PL   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-GR   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001145-11-BG   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
GH sampling - every 20 min over 24 hours   
   Christie Hospital NHS Foundation Trust
      2004   -   NCT00468624   United Kingdom;
GH substitution   
   University of Aarhus
      2016   -   NCT02782208   Denmark;
GHRH   
   Helsinki University Central Hospital
      2001   -   NCT03018886   Finland;
   Merck KGaA
      2004   Phase 3   NCT01060488   France;
GHRH/arginine stimulation testing   
   Children's Mercy Hospital Kansas City
      2007   -   NCT00324064   United States;
GX-H9   
   Genexine, Inc
      2015   Phase 2   EUCTR2014-002698-13-SK   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-SE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-PL   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-HU   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-GR   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-DE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
   Genexine, Inc.
      2016   Phase 2   NCT03309891   Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-PL   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LV   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LT   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-EE   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   NCT02946606   Korea, Republic of;
      2015   Phase 2   EUCTR2015-001939-21-SK   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-HU   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-CZ   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   -   EUCTR2015-001939-21-GR   Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Gastrointestinal evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Gelatin   
   Top Institute Food and Nutrition
      -   -   EUCTR2010-018781-23-NL   Netherlands;
Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin)   
   Pfizer, S.A
      2007   Phase 4   EUCTR2007-003586-41-ES   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin)   
   Pfizer, S.A
      2007   Phase 4   EUCTR2007-003586-41-ES   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotropin   
   Ascendis Pharma A/S
      2013   Phase 2   EUCTR2012-002787-27-SI   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-GR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-DE   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-CZ   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-HU   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-BG   Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      -   Phase 2   EUCTR2012-002787-27-FR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
   BioPartners GmbH
      2006   -   EUCTR2005-000346-36-LT   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-SE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-FI   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-DE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
   Cristália Produtos Químicos Farmacêuticos Ltda.
      -   -   EUCTR2016-000446-56-Outside-EU/EEA   Brazil;
   Ferring Pharmaceuticals
      2010   Phase 3   NCT00884000   Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine;
   Genexine, Inc.
      2016   Phase 2   NCT03309891   Ukraine;
      2015   Phase 2   NCT02946606   Korea, Republic of;
   Hanmi Pharmaceutical Co., Ltd.
      2014   -   EUCTR2011-001826-61-BG   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2012   -   EUCTR2011-001826-61-PL   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2011   -   EUCTR2011-001826-61-HU   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
   Hanmi Pharmaceutical Company Limited
      2011   Phase 2   NCT01822340   Hungary;Romania;
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   OPKO Biologics Ltd.
      2017   Phase 3   EUCTR2016-003874-42-GR   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-GB   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-ES   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-DE   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-BG   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004553-60-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   Phase 2   EUCTR2011-004553-60-HU   Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-SK   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
      -   Phase 3   EUCTR2016-003874-42-PL   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-003874-42-FR   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
   OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
      2017   Phase 3   JPRN-JapicCTI-183963   Japan;
   OPKO Health, Inc.
      2017   Phase 3   NCT03874013   Japan;
   PFIZER
      2008   -   EUCTR2007-003586-41-IT   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
   PRM|21097
      2017   Phase 3   EUCTR2016-003874-42-IT   Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
   PROLOR Biotech Ltd.
      2012   -   EUCTR2011-004553-60-GR   Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
      2012   -   EUCTR2011-004553-60-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
   Pfizer
      2019   Phase 3   NCT03831880   Bulgaria;Czechia;Slovakia;United Kingdom;United States;
      2008   Phase 4   NCT00555009   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
   Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2007   -   EUCTR2007-003586-41-SE   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003586-41-NL   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003586-41-GB   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
   Radboud University Nijmegen Medical Centre, Department of Endocrinology
      2006   Phase 4   EUCTR2006-001574-24-NL   Netherlands;
   Teva Pharmaceutical Industries Ltd.
      2016   -   EUCTR2014-002736-13-PL   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SI   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HU   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-GR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-DE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-CZ   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-AT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-SK   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-LT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-IT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-ES   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
   Teva Pharmaceutical Industries, Ltd.
      2015   Phase 2   EUCTR2013-004468-69-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   Phase 2   EUCTR2013-004468-69-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   -   EUCTR2013-004468-69-ES   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-HU   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-GR   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
      -   Phase 2   EUCTR2013-004468-69-RO   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
   VU University Medical Center
      2013   -   EUCTR2012-005066-36-NL   Netherlands;
Genotropin (PN-180,307) Somatropin   
   Pfizer
      2007   Phase 4   NCT00432263   -
Genotropin 12 mg/ml   
   Ferring Pharmaceuticals A/S
      2009   -   EUCTR2008-004849-28-HU   Hungary;
Genotropin 5 mg/ml   
   Pfizer Pharma GmbH
      2008   -   EUCTR2007-000790-36-DE   Germany;
Genotropin 5.3 mg in injection system Genotropin pen   
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2010   Phase 3   EUCTR2009-017354-12-SK   Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
Genotropin GoQuick   
   Pfizer Inc.
      2019   Phase 3   EUCTR2018-000918-38-SK   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-GB   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-CZ   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-BG   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Genotropin Mark VII pen   
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2010   Phase 3   EUCTR2009-017354-12-SK   Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2009-017354-12-GB   Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
      2010   -   EUCTR2009-017354-12-SE   Czech Republic;Germany;Sweden;United Kingdom;
      2010   -   EUCTR2009-017354-12-DE   Czech Republic;Germany;Sweden;United Kingdom;
      2010   -   EUCTR2009-017354-12-CZ   Czech Republic;Germany;Sweden;United Kingdom;
      -   Phase 3   EUCTR2009-017354-12-NL   Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
Genotropin MiniQuick   
   Dr. Chris Thompson
      2006   -   EUCTR2005-005613-38-IE   Ireland;
Genotropin Miniqu   
   Amar Agha, Beaumont Hospital
      2009   -   EUCTR2009-010918-30-IE   Ireland;
Genotropin Miniquick   
   Amar Agha, Beaumont Hospital
      2009   -   EUCTR2009-010918-30-IE   Ireland;
Genotropin miniquick 0.5 mg, injection   
   University of Aarhus
      2019   -   NCT03878992   Denmark;
Genotropin, Genotropin MiniQuick   
   Sahlgrenska University Hospital
      2010   -   EUCTR2009-016783-37-SE   Sweden;
Genotropin/GENOTONORM®   
   Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2008   -   EUCTR2007-003586-41-FR   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotropin®   
   Genexine, Inc
      2015   Phase 2   EUCTR2014-002698-13-SK   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-SE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-PL   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-HU   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-GR   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-DE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
   Genexine, Inc.
      2016   Phase 2   EUCTR2015-001939-21-PL   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LV   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LT   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-EE   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-SK   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-HU   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-CZ   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   -   EUCTR2015-001939-21-GR   Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
   Teva Pharmaceutical Industries Ltd.
      2013   Phase 2   EUCTR2012-004975-37-DE   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SK   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SI   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-SE   Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-HU   Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-GR   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-CZ   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Ghrelin   
   University of Aarhus
      2012   -   NCT01209416   Denmark;
Glucagon stimulation test and insulin tolerance test   
   The Cleveland Clinic
      2011   -   NCT01282164   United States;
Growth Factors Laboratory Testing   
   The University of Texas Health Science Center at San Antonio
      2001   Phase 3   NCT00134420   United States;
Growth Hormone Replacement Therapy   
   University of Liverpool
      2014   -   NCT02243852   United Kingdom;
Growth Hormone, GH   
   University of Birmingham
      2005   -   EUCTR2004-004835-72-GB   United Kingdom;
Growth Hormone-Releasing Hormone   
   Stefania La Grutta, MD
      2014   -   NCT02507245   -
Growth hormone   
   Columbia University
      2017   -   NCT03225755   United States;
   Ferring Pharmaceuticals
      2007   -   NCT01365351   Germany;
   LG Life Sciences
      2006   Phase 3   NCT00294619   United States;
   National Center for Research Resources (NCRR)
      1997   -   NCT00006394   United States;
   Ohio State University
      2005   Phase 4   NCT00373386   United States;
   Royal Liverpool University hospital
      2006   Phase 4   EUCTR2005-004316-73-GB   United Kingdom;
   University Hospital, Angers
      2005   -   NCT00187993   France;
   University of Palermo
      2016   -   NCT03203356   Italy;
Growth hormone (Genotonorm® or Omnitrope®)   
   University Hospital, Toulouse
      2009   Phase 4   NCT01298180   France;
Growth hormone (Genotropin)   
   Oregon Health and Science University
      2006   Phase 0   NCT00517062   United States;
Growth hormone (Nutropin)   
   Baylor College of Medicine
      2006   -   NCT00362063   United States;
Growth hormone (genotropin)   
   University of Aarhus
      2008   -   NCT00646815   Denmark;
Growth hormone (somatropin)   
   LG Life Sciences
      2005   Phase 3   NCT00271518   United States;
Growth hormone - LB03002   
   LG Life Sciences
      2006   Phase 3   NCT00596037   United States;
Growth hormone administration for 6 months   
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2005   -   NCT00149708   Brazil;
Growth hormone releasing hormone (GHRH) 1-44   
   Massachusetts General Hospital
      2008   Phase 2   NCT00675506   United States;
Growth hormone releasing hormone (GHRH) and arginine   
   Columbia University
      2007   -   NCT00720902   United States;
Growth hormone replacement therapy in growth hormone deficient patients only.   
   University Hospital Inselspital, Berne
      2007   -   NCT00491582   Switzerland;
H01AC01   
   Sahlgrenska University Hospital
      2010   -   EUCTR2009-016783-37-SE   Sweden;
HGH   
   Beckert Michael
      2021   Phase 3   JPRN-jRCT2051200129   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
      2021   Phase 3   JPRN-jRCT2031200340   Japan;
HGH-ViaDerm™ System (hGH or somatropin)   
   Teva Neuroscience, Inc.
      2007   Phase 1   NCT00455260   Israel;Ukraine;
HGH-hyFc, recombinant human growth hormone   
   Genexine, Inc
      2015   Phase 2   EUCTR2014-002698-13-SK   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-SE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-PL   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-HU   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-GR   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-DE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
   Genexine, Inc.
      2016   Phase 2   EUCTR2015-001939-21-PL   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LV   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LT   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-EE   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-SK   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-HU   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-CZ   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   -   EUCTR2015-001939-21-GR   Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
HM10560A   
   Hanmi Pharmaceutical Co., Ltd.
      2014   -   EUCTR2011-001826-61-BG   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2012   -   EUCTR2011-001826-61-PL   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2011   -   EUCTR2011-001826-61-HU   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
   Hanmi Pharmaceutical Company Limited
      2011   Phase 2   NCT01822340   Hungary;Romania;
HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)   
   Teva Pharmaceutical Industries Ltd.
      2016   -   EUCTR2014-002736-13-PL   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SI   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HU   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-GR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-DE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-CZ   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-AT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-SK   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-LT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-IT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-ES   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Humalog Mix50 100 U/ml sospensione iniettabile   
   AETERNA ZENTARIS GMBH
      2016   Phase 3   EUCTR2015-002337-22-IT   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Human Growth Hormone (1-134)   
   Stanford University
      2009   Phase 3   NCT01007071   United States;
Human Serum Albumin (HSA) fused to somatropin   
   Teva Pharmaceutical Industries Ltd.
      2013   Phase 2   EUCTR2012-004975-37-DE   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SK   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SI   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-SE   Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-HU   Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-GR   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-CZ   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
   Teva Pharmaceutical Industries, Ltd.
      2015   Phase 2   EUCTR2013-004468-69-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   Phase 2   EUCTR2013-004468-69-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   -   EUCTR2013-004468-69-ES   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-HU   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-GR   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
      -   Phase 2   EUCTR2013-004468-69-RO   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Human acylated ghrelin   
   University of Aarhus
      2005   -   NCT00139945   Denmark;
Human growth hormone   
   Federico II University
      2019   Phase 3   NCT03775993   -
Humatrope   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   VU University Medical Center
      2013   -   EUCTR2012-005066-36-NL   Netherlands;
Humatrope® 6 mg, powder and solvent for solution for injection   
   Ascendis Pharma Endocrinology Division A/S
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Hydrocortisone   
   Amar Agha
      2008   -   EUCTR2007-005018-37-IE   Ireland;
   University Hospital Inselspital, Berne
      2015   -   NCT02360046   Switzerland;
Hydrocortisone TAKEDA, tabletter   
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark;
Hydrocortone   
   Amar Agha
      2008   -   EUCTR2007-005018-37-IE   Ireland;
   Bradford Teaching Hospitals NHS Foundation Trust
      2004   Phase 4   EUCTR2004-002056-34-GB   United Kingdom;
Hydrokortison Glostrup   
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark;
INCRELEX 10 mg/ml   
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-SE   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-GB   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-FI   Finland;Spain;Sweden;United Kingdom;
INCRELEX 10 mg/ml, solución inyectable   
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-ES   Finland;Spain;Sweden;United Kingdom;
Insulin   
   AETERNA ZENTARIS GMBH
      2016   Phase 3   EUCTR2015-002337-22-IT   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
   AEterna Zentaris
      2015   Phase 3   NCT02558829   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Intravenous Infusion of Diclofenac Sodium   
   Azienda Ospedaliera Città della Salute e della Scienza di Torino
      2021   Phase 4   NCT05188131   Italy;
Jintropin AQ   
   GeneScience Pharmaceuticals Co., Ltd.
      2006   Phase 2   NCT01342146   -
L-ARG+GHRH   
   AEterna Zentaris
      2007   Phase 3   NCT00448747   United States;
LB03002   
   BIOPARTNERS GMBH
      2007   -   EUCTR2006-002278-24-IT   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2005-000384-26-IT   Czech Republic;Germany;Italy;Spain;Sweden;United Kingdom;
   BioPartners GmbH
      2015   Phase 3   EUCTR2005-000384-26-FR   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2006-002278-24-GB   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-FR   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-ES   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-DE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-CZ   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2005-000346-36-LT   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   Phase 3   EUCTR2005-000384-26-SK   Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2005-000384-26-GB   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-SE   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-DE   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-CZ   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000346-36-SE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-FI   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-DE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
   LG Life Science Ltd.
      2005   -   EUCTR2005-000384-26-ES   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-AT   Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
   LG Life Sciences Ltd.
      2007   Phase 3   EUCTR2006-002278-24-SK   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-AT   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
LUM-201   
   Lumos Pharma
      2022   Phase 2   NCT05250063   United States;
      2021   Phase 2   NCT04806854   Chile;
      2020   Phase 2   NCT04614337   Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
   Lumos Pharma, Inc.
      2021   Phase 2   EUCTR2020-000874-92-PL   Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Levothyroxine   
   Christie Hospital NHS Trust
      2005   -   EUCTR2004-005184-15-GB   United Kingdom;
   Rigshospitalet, Denmark
      2012   -   NCT01574859   Denmark;
Lonapegsomatropin   
   Ascendis Pharma Endocrinology Division A/S
      2021   Phase 3   NCT05171855   United States;
      2020   Phase 3   NCT04615273   Armenia;Australia;Canada;Georgia;Greece;Japan;Poland;Slovakia;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-PL   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-IT   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-BG   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2016-001145-11-DE   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-PL   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001145-11-BG   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Beckert Michael
      2021   Phase 3   JPRN-jRCT2051200129   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
      2021   Phase 3   JPRN-jRCT2031200340   Japan;
Lonapegsomatropin drug product   
   Ascendis Pharma Endocrinology Division A/S
      2022   Phase 3   EUCTR2020-000929-42-BG   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-IT   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-ES   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Long-Acting Growth Hormone (LAGH)   
   University of Minnesota
      2021   -   NCT04938466   United States;
MACIMORELIN ACETATE   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
   Aeterna Zentaris GmbH
      2021   Phase 3   EUCTR2018-001989-42-PL   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
      2019   Phase 2   EUCTR2018-001988-23-PL   Belarus;Hungary;Poland;Russian Federation;Serbia;Ukraine;
      2018   Phase 2   EUCTR2018-001988-23-HU   Hungary;Poland;Russian Federation;Serbia;Ukraine;
      -   Phase 3   EUCTR2018-001989-42-DE   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
MOD-4023   
   ModigeneTech Ltd.
      2011   -   EUCTR2010-019374-32-AT   Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      -   -   EUCTR2010-019374-32-DE   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   OPKO Biologics Ltd.
      2017   Phase 3   EUCTR2016-003874-42-GR   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-GB   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-ES   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-DE   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-BG   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-000830-37-PL   Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-000830-37-NL   Austria;France;Germany;Greece;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2013-000830-37-SK   Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2013-000830-37-HU   Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2013-000830-37-GB   Armenia;Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2013-000830-37-AT   Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004553-60-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   Phase 2   EUCTR2011-004553-60-HU   Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-SK   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
      -   Phase 3   EUCTR2016-003874-42-PL   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-003874-42-FR   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
   OPKO Health, Inc.
      2017   Phase 3   NCT03874013   Japan;
      2016   Phase 3   NCT02968004   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;Georgia;Germany;Greece;India;Israel;Italy;Korea, Republic of;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 1   NCT02418767   United States;
      2013   Phase 3   NCT01909479   Israel;United States;
      2013   Phase 2   NCT02500316   Belarus;Greece;Hungary;Russian Federation;Slovakia;Ukraine;United States;
      2012   Phase 2   NCT01592500   Greece;Hungary;Slovakia;
      2010   Phase 2   NCT01225666   Czech Republic;Czechia;Hungary;Israel;Serbia;Slovakia;Slovenia;
   PRM|21097
      2017   Phase 3   EUCTR2016-003874-42-IT   Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
   PROLOR Biotech Ltd.
      2013   Phase 3   EUCTR2013-000830-37-GR   Austria;France;Germany;Greece;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2013-000830-37-ES   Austria;France;Germany;Greece;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004553-60-GR   Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
      2012   -   EUCTR2011-004553-60-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
   Prolor Biotech Ltd
      2010   -   EUCTR2010-019374-32-CZ   Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
MRI   
   Columbia University
      2007   -   NCT00720902   United States;
Macimorelin   
   AEterna Zentaris
      2021   Phase 3   NCT04786873   United States;
      2015   Phase 3   NCT02558829   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Macimorelin Consilient Health   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
   Aeterna Zentaris GmbH
      2021   Phase 3   EUCTR2018-001989-42-PL   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
      -   Phase 3   EUCTR2018-001989-42-DE   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
Macimorelin acetate   
   AETERNA ZENTARIS GMBH
      2016   Phase 3   EUCTR2015-002337-22-IT   Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Macimorelina   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Macrilen   
   Aeterna Zentaris GmbH
      2019   Phase 2   EUCTR2018-001988-23-PL   Belarus;Hungary;Poland;Russian Federation;Serbia;Ukraine;
      2018   Phase 2   EUCTR2018-001988-23-HU   Hungary;Poland;Russian Federation;Serbia;Ukraine;
Magnetic resonance imaging of the brain   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Measurement of growth, thyroid and sex hormone levels   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Mecasermin   
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-SE   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-GB   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-FI   Finland;Spain;Sweden;United Kingdom;
NDC0009-0436-01   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
   Aeterna Zentaris GmbH
      2021   Phase 3   EUCTR2018-001989-42-PL   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
      -   Phase 3   EUCTR2018-001989-42-DE   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
NN-220   
   Novo Nordisk A/S
      -   Phase 3   EUCTR2017-000914-47-Outside-EU/EEA   Japan;
NN8630   
   Novo Nordisk A/S
      2008   -   EUCTR2008-001061-29-DK   Denmark;
NN8640   
   NOVO NORDISK. S.P.A.
      2019   Phase 3   EUCTR2018-000231-27-IT   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
NNC 126-0083   
   Novo Nordisk A/S
      2009   Phase 2   EUCTR2008-008240-25-FR   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   Phase 2   EUCTR2008-008240-25-ES   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-SI   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-GB   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-DK   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-BE   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2008   -   EUCTR2008-001061-29-DK   Denmark;
NNC0195-0092 10 mg/1.5 ml PDS290-10   
   Novo Nordisk A/S
      2016   Phase 2   EUCTR2015-000531-32-SE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-DE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-BE   Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-SI   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-AT   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 15 mg/1.5 ml PDS290-15   
   Novo Nordisk A/S
      2016   Phase 2   EUCTR2015-000531-32-SE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-DE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-BE   Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-SI   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-AT   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 5 mg/1.5 ml PDS290-10   
   Novo Nordisk A/S
      2016   Phase 2   EUCTR2015-000531-32-SE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-DE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-BE   Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-SI   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-AT   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 DP 6.7 mg ml 3 ml cartridge   
   Novo Nordisk A/S
      2014   Phase 1   EUCTR2013-000013-20-ES   Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-SI   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-SE   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-BE   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-AT   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      -   Phase 1   EUCTR2013-000013-20-FR   Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
NNC0195-0092 PDS290 10 mg-1.5 ml   
   Novo Nordisk A/S
      2015   Phase 3   EUCTR2013-002892-16-LV   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2013-002892-16-LT   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-002892-16-SE   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-002892-16-GB   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002892-16-DE   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 PDS290 10 mg/1.5 ml   
   Novo Nordisk A/S
      2015   Phase 3   EUCTR2014-000290-39-GB   Denmark;European Union;Japan;Sweden;United Kingdom;
      2015   -   EUCTR2014-000290-39-DK   Denmark;European Union;Japan;Sweden;United Kingdom;
      2014   -   EUCTR2014-000290-39-SE   Denmark;European Union;Japan;Sweden;United Kingdom;
NNC126-0083   
   Novo Nordisk A/S
      2009   Phase 2   NCT00936403   Belgium;Czech Republic;Denmark;France;Israel;Macedonia, The Former Yugoslav Republic of;Slovenia;Spain;Turkey;United Kingdom;
      2008   Phase 2   NCT00715689   Denmark;
NUTROPIN   
   Guillem Cuatrecasas Cambra
      2012   Phase 2   EUCTR2011-005377-23-ES   Spain;
NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable   
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-ES   Finland;Spain;Sweden;United Kingdom;
Neurology examination   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Neuropsychological Testing   
   The University of Texas Health Science Center at San Antonio
      2001   Phase 3   NCT00134420   United States;
Niacin First   
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2011   Phase 1/Phase 2   NCT01237041   United States;
None   
   Genexine, Inc.
      2016   Phase 2   EUCTR2015-001939-21-PL   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LV   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LT   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-EE   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-SK   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-HU   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-CZ   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   -   EUCTR2015-001939-21-GR   Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
NordiFlex   
   I-Mab Biopharma Co. Ltd.
      2021   Phase 3   NCT04633057   China;
Nordilet®   
   Cinnagen
      2016   Phase 3   NCT03223025   -
Norditropin   
   Lumos Pharma, Inc.
      2021   Phase 2   EUCTR2020-000874-92-PL   Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
   Novo Nordisk A/S
      2017   Phase 3   NCT03075644   Japan;
   Novo Nordisk Farma Oy
      2009   Phase 4   EUCTR2008-001674-32-FI   Finland;
   VU University Medical Center
      2013   -   EUCTR2012-005066-36-NL   Netherlands;
Norditropin FlexPro   
   Novo Nordisk A/S
      2016   Phase 2   EUCTR2015-000531-32-BE   Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-000290-39-GB   Denmark;European Union;Japan;Sweden;United Kingdom;
      2015   Phase 3   EUCTR2013-002892-16-LV   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2013-002892-16-LT   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-000290-39-DK   Denmark;European Union;Japan;Sweden;United Kingdom;
      2014   Phase 3   EUCTR2013-002892-16-SE   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-002892-16-GB   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002892-16-DE   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2014   -   EUCTR2014-000290-39-SE   Denmark;European Union;Japan;Sweden;United Kingdom;
Norditropin FlexPro 10 mg/1.5 ml   
   NOVO NORDISK. S.P.A.
      2019   Phase 3   EUCTR2018-000231-27-IT   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
   Novo Nordisk A/S
      2020   Phase 3   EUCTR2018-000231-27-PL   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-LV   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-HU   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-ES   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-EE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-SI   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-GB   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DK   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-AT   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-000531-32-SE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2016   Phase 2   EUCTR2015-000531-32-DE   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-SI   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 2   EUCTR2015-000531-32-AT   Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      -   Phase 3   EUCTR2018-000231-27-NO   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-IE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-FR   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5 mg/1.5 mL   
   Ascendis Pharma Endocrinology Division A/S
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5 mg/1.5 ml   
   Ascendis Pharma Endocrinology Division A/S
      2021   Phase 3   EUCTR2020-000929-42-IT   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5mg/1.5 ml   
   Ascendis Pharma Endocrinology Division A/S
      2021   Phase 3   EUCTR2020-000929-42-IT   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Norditropin Growth Hormone   
   Duke University
      2007   -   NCT00615953   United States;
Norditropin NordiFlex®   
   Novo Nordisk A/S
      2012   Phase 1   NCT01706783   Denmark;Sweden;
      2011   -   NCT01327924   France;
Norditropin NordiFlex® 10 mg/1.5 ml   
   Novo Nordisk A/S
      2009   Phase 2   EUCTR2008-008240-25-FR   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   Phase 2   EUCTR2008-008240-25-ES   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-SI   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-GB   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-DK   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-BE   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
Norditropin NordiFlex® 10mg/1.5 ml   
   Novo Nordisk A/S
      2009   Phase 2   EUCTR2008-008240-25-FR   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   Phase 2   EUCTR2008-008240-25-ES   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-SI   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-GB   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-DK   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-BE   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
Norditropin SimpleXx   
   Karolinska universitetssjukhuset
      2006   -   EUCTR2005-004478-26-SE   Sweden;
   Novo Nordisk A/S
      2014   Phase 1   EUCTR2013-000013-20-ES   Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-SI   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-SE   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-BE   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2013   -   EUCTR2013-000013-20-AT   Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      -   Phase 1   EUCTR2013-000013-20-FR   Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
Norditropin SimpleXx (growth hormone)   
   Aarhus University Hospital
      2010   Phase 2   NCT01090778   Denmark;
Norditropin SimpleXx 5mg/1.5ml   
   University of Birmingham
      2005   -   EUCTR2004-004835-72-GB   United Kingdom;
Norditropin Simplex   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)   
   Endocrine Department, Sahlgrenska University Hospital
      2005   -   EUCTR2004-004292-11-SE   Sweden;
Norditropin®   
   Novo Nordisk A/S
      2021   Phase 3   NCT04970654   China;
      2019   Phase 3   NCT03811535   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
   Xiamen Amoytop Biotech Co., Ltd.
      2018   Phase 2/Phase 3   NCT04513171   China;
Norditropin® FlexPro®   
   Novo Nordisk A/S
      2019   -   NCT03972345   Germany;
Norditropin® FlexPro® pen   
   Novo Nordisk A/S
      2016   Phase 2   NCT02616562   Austria;Belgium;Brazil;France;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
Norditropin® SimpleXx® 5 mg/1.5ml   
   Medical Department M (Endocrinology & Diabetes)
      2010   Phase 2   EUCTR2010-018586-39-DK   Denmark;
NuSpin   
   Genentech, Inc.
      2010   -   NCT01243892   United States;
Nutritional supplementation standardized formula   
   Rabin Medical Center
      2017   -   NCT03053687   Israel;
Nutropin AQ   
   Children's Hospital Los Angeles
      2004   Phase 4   NCT00140413   United States;
   Oregon Health and Science University
      2005   Phase 4   NCT00212758   United States;
   The University of Texas Health Science Center at San Antonio
      2001   Phase 3   NCT00134420   United States;
Nutropin Aq   
   CHU Amiens
      2010   -   EUCTR2010-019735-35-FR   France;
NutropinAq   
   Beaufour Ipsen Pharma
      2005   -   EUCTR2004-000356-17-DK   Denmark;Finland;Italy;
      2005   -   EUCTR2004-000356-17-AT   Austria;Denmark;Finland;Italy;
   CHU Amiens
      2010   -   EUCTR2010-019735-35-FR   France;
   Ipsen Scandinavia
      2006   -   EUCTR2004-000356-17-FI   Denmark;Finland;Italy;
      -   Phase 4   EUCTR2004-000356-17-SE   Austria;Denmark;Finland;Italy;Spain;Sweden;
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
NutropinAq 10 mg/2 ml   
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-SE   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-GB   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-FI   Finland;Spain;Sweden;United Kingdom;
NutropinAq 10 mg/2 ml (30 UI)   
   Guillem Cuatrecasas Cambra
      2012   Phase 2   EUCTR2011-005377-23-ES   Spain;
OMNITROPE   
   ASCENDIS PHARMA A/S
      2010   -   EUCTR2010-021523-28-IT   Austria;Denmark;Germany;Italy;Sweden;
Oestrogen   
   University of Aarhus
      2001   -   NCT00572390   Denmark;
Omnitrop   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Omnitrope   
   Ascendis Pharma A/S
      2010   Phase 2   NCT01247675   Denmark;Germany;Italy;Sweden;
Omnitrope®   
   Ascendis Pharma A/S
      2010   -   EUCTR2010-021523-28-SE   Austria;Denmark;Germany;Italy;Sweden;
      2010   -   EUCTR2010-021523-28-DK   Austria;Denmark;Germany;Italy;Sweden;
      2010   -   EUCTR2010-021523-28-DE   Austria;Denmark;Germany;Italy;Sweden;
      2010   -   EUCTR2010-021523-28-AT   Austria;Denmark;Germany;Italy;Sweden;
Once daily subcutaneous injection of Genotropin   
   Ascendis Pharma Endocrinology Division A/S
      2016   Phase 3   NCT02781727   Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
Once weekly subcutaneous injection of TransCon hGH   
   Ascendis Pharma Endocrinology Division A/S
      2016   Phase 3   NCT02781727   Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
Only medicinal products registered in Austria will be used in this clinical trial.   
   ModigeneTech Ltd.
      2011   -   EUCTR2010-019374-32-AT   Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Only medicinal products registered in Germany will be used in this clinical trial   
   ModigeneTech Ltd.
      -   -   EUCTR2010-019374-32-DE   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Ophthalmologic evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Orthopedic evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
PEG-somatropin   
   GeneScience Pharmaceuticals Co., Ltd.
      2017   Phase 4   NCT03290235   China;
      2015   Phase 4   NCT03249480   China;
      2015   Phase 4   NCT02976675   China;
      2014   Phase 4   NCT02908958   China;
      2014   Phase 4   NCT02380235   China;
      2014   Phase 4   NCT02314676   China;
      2007   Phase 3   NCT01495468   China;
PF-06836922   
   Pfizer Inc.
      2019   Phase 3   EUCTR2018-000918-38-SK   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-GB   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-CZ   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-BG   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
PHA-794,428   
   PFIZER
      2006   -   EUCTR2005-005587-82-IT   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer
      2006   -   EUCTR2005-005587-82-NL   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer Limited
      2007   -   EUCTR2005-005587-82-CZ   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
      2006   -   EUCTR2005-005587-82-GB   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
      2006   -   EUCTR2005-005587-82-DK   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer Ltd
      2007   Phase 2   EUCTR2005-005587-82-PL   Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
      2007   -   EUCTR2005-005587-82-GR   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer NV/SA
      2006   -   EUCTR2005-005587-82-BE   Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer Pharma GmbH
      2006   -   EUCTR2005-005587-82-DE   Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
PHA-794428   
   Pfizer
      2006   Phase 2   NCT00314938   Belgium;France;Germany;Israel;Spain;United Kingdom;
      2006   Phase 2   NCT00308464   Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;
   Pfizer Global Research and Development
      2005   -   EUCTR2005-001658-25-BE   Belgium;
   Pfizer Limited
      2006   -   EUCTR2005-005593-79-GB   Germany;Spain;United Kingdom;
   Pfizer N.V./S.A.
      2006   -   EUCTR2005-005593-79-BE   Belgium;Germany;Spain;United Kingdom;
   Pfizer Pharma GmbH
      2006   -   EUCTR2005-005593-79-DE   Germany;Spain;United Kingdom;
   Pfizer SA
      2006   Phase 2   EUCTR2005-005593-79-ES   Belgium;Germany;Spain;United Kingdom;
PN-180307   
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2010   Phase 3   EUCTR2009-017354-12-SK   Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2009-017354-12-GB   Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
      2010   -   EUCTR2009-017354-12-SE   Czech Republic;Germany;Sweden;United Kingdom;
      2010   -   EUCTR2009-017354-12-DE   Czech Republic;Germany;Sweden;United Kingdom;
      2010   -   EUCTR2009-017354-12-CZ   Czech Republic;Germany;Sweden;United Kingdom;
      -   Phase 3   EUCTR2009-017354-12-NL   Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
Pegvisomant   
   Oregon Health and Science University
      2011   -   NCT01804413   United States;
Pegylated Somatropin   
   GeneScience Pharmaceuticals Co., Ltd.
      2006   Phase 2   NCT01342146   -
Pegylated polypeptide hormone of human recombinant origin PEG-hGH   
   Pfizer
      2006   -   EUCTR2005-005587-82-NL   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer Limited
      2007   -   EUCTR2005-005587-82-CZ   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
      2006   -   EUCTR2005-005593-79-GB   Germany;Spain;United Kingdom;
      2006   -   EUCTR2005-005587-82-GB   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
      2006   -   EUCTR2005-005587-82-DK   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer Ltd
      2007   Phase 2   EUCTR2005-005587-82-PL   Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
      2007   -   EUCTR2005-005587-82-GR   Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer N.V./S.A.
      2006   -   EUCTR2005-005593-79-BE   Belgium;Germany;Spain;United Kingdom;
   Pfizer NV/SA
      2006   -   EUCTR2005-005587-82-BE   Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer Pharma GmbH
      2006   -   EUCTR2005-005593-79-DE   Germany;Spain;United Kingdom;
      2006   -   EUCTR2005-005587-82-DE   Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
   Pfizer SA
      2006   Phase 2   EUCTR2005-005593-79-ES   Belgium;Germany;Spain;United Kingdom;
Pegylated recombinant human growth hormone   
   Ambrx, Inc., USA
      2008   -   EUCTR2007-001746-40-HU   Hungary;
Pegylated somatropin   
   GeneScience Pharmaceuticals Co., Ltd.
      2010   Phase 1   NCT01613573   -
Phosphate sandoz   
   Royal Liverpool University hospital
      2006   Phase 4   EUCTR2005-004316-73-GB   United Kingdom;
Pioglitazone   
   University of Aarhus
      2004   -   NCT00459940   Denmark;
Plenadren 20 mg modified-release tablets   
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark;
Plenadren 5 mg modified-release tablets   
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark;
Polyethylene glycol   
   The Children's Hospital of Zhejiang University School of Medicine
      2021   Phase 4   ChiCTR2100048579   China;
Psychiatric evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
R-Gene   
   AETERNA ZENTARIS GMBH
      2021   Phase 3   EUCTR2018-001989-42-IT   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
R-Gene 10   
   Aeterna Zentaris GmbH
      2021   Phase 3   EUCTR2018-001989-42-PL   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
      -   Phase 3   EUCTR2018-001989-42-DE   Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
R-hGH   
   Merck KGaA
      2003   Phase 4   NCT01157793   -
R-hGH freeze-dried   
   EMD Serono
      2008   Phase 1   NCT01034735   Germany;
R-hGH liquid (Saizen)   
   EMD Serono
      2008   Phase 1   NCT01034735   Germany;
RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH)   
   Teva Pharmaceutical Industries Ltd.
      2016   -   EUCTR2014-003796-32-PL   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-SI   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-HR   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-GR   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-DE   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-CZ   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-AT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-SK   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-RO   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-LT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-IT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-HU   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-ES   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-BG   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
RVG 15790 or RVG 25480   
   Radboud University Nijmegen Medical Centre, Department of Endocrinology
      2006   Phase 4   EUCTR2006-001574-24-NL   Netherlands;
Recombinanat DNA-derived human growth hormone produced in E.coli   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Recombinant DNA-derived human growth hormone   
   Ascendis Pharma A/S
      2013   Phase 2   EUCTR2012-002787-27-SI   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-GR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-DE   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-CZ   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-HU   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-BG   Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      -   Phase 2   EUCTR2012-002787-27-FR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
   Ascendis Pharma Endocrinology Division A/S
      2018   Phase 3   EUCTR2016-001145-11-DE   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-PL   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-GR   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001145-11-BG   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Genexine, Inc
      2015   Phase 2   EUCTR2014-002698-13-SK   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-SE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-PL   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-HU   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-GR   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-DE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
   Genexine, Inc.
      2016   Phase 2   EUCTR2015-001939-21-PL   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LV   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-LT   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2016   Phase 2   EUCTR2015-001939-21-EE   Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-SK   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-HU   Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
      2015   Phase 2   EUCTR2015-001939-21-CZ   Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
      2015   -   EUCTR2015-001939-21-GR   Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
   Hanmi Pharmaceutical Co., Ltd.
      2014   -   EUCTR2011-001826-61-BG   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2012   -   EUCTR2011-001826-61-PL   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2011   -   EUCTR2011-001826-61-HU   Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
   ModigeneTech Ltd.
      2011   -   EUCTR2010-019374-32-AT   Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      -   -   EUCTR2010-019374-32-DE   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   Prolor Biotech Ltd
      2010   -   EUCTR2010-019374-32-CZ   Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Recombinant DNA-derived human growth hormone produced in E.coli   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   OPKO Biologics Ltd.
      2013   -   EUCTR2011-004553-60-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   Phase 2   EUCTR2011-004553-60-HU   Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-SK   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
   PROLOR Biotech Ltd.
      2012   -   EUCTR2011-004553-60-GR   Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
      2012   -   EUCTR2011-004553-60-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Recombinant Growth Hormone, Genotropin (Pfizer)   
   Federico II University
      1996   -   NCT00462475   Italy;
Recombinant Human Gowth Hormone   
   Teva Pharmaceutical Industries Ltd.
      2016   -   EUCTR2014-002736-13-PL   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SI   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HU   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-GR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-DE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-CZ   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-AT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-SK   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-LT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-IT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-ES   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
   Teva Pharmaceutical Industries, Ltd.
      2015   Phase 2   EUCTR2013-004468-69-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   Phase 2   EUCTR2013-004468-69-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   -   EUCTR2013-004468-69-ES   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-HU   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-GR   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
      -   Phase 2   EUCTR2013-004468-69-RO   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Recombinant growth hormone   
   University Medical Center St Radboud, department of neurology
      2007   -   EUCTR2006-005442-37-NL   Netherlands;
Recombinant human Growth Hormone (Genotropin® )   
   Charite University, Berlin, Germany
      2003   Phase 4   NCT00929799   Germany;
Recombinant human Growth Hormone (rhGH)   
   Ascendis Pharma A/S
      2013   Phase 2   EUCTR2012-002787-27-SI   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-DE   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-CZ   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-HU   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-BG   Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      -   Phase 2   EUCTR2012-002787-27-FR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
   ModigeneTech Ltd.
      2011   -   EUCTR2010-019374-32-AT   Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      -   -   EUCTR2010-019374-32-DE   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   Prolor Biotech Ltd
      2010   -   EUCTR2010-019374-32-CZ   Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Recombinant human Growth Hormone(rhGH)   
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Recombinant human IGF-1   
   Columbia University
      2008   -   NCT00684957   United States;
Recombinant human growth hormone   
   EMD Serono
      2005   Phase 3   NCT00109733   United States;
   Huashan Hospital Affiliated to Fudan University
      2020   Phase 0   ChiCTR2000039505   China;
   Lumos Pharma, Inc.
      2021   Phase 2   EUCTR2020-000874-92-PL   Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
   Massachusetts General Hospital
      2004   -   NCT00182091   United States;
   Sahlgrenska University Hospital
      2010   -   EUCTR2009-016783-37-SE   Sweden;
   Teva Branded Pharmaceutical Products R&D, Inc.
      2013   Phase 2   NCT01811576   Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
   The Children's Hospital of Zhejiang University School of Medicine
      2021   Phase 4   ChiCTR2100048579   China;
   The University of Texas Medical Branch, Galveston
      2003   Phase 4   NCT00957671   United States;
Recombinant human growth hormone (r-hGH)   
   Merck KGaA
      2007   Phase 4   NCT01187550   -
Recombinant human growth hormone (rhGH)   
   BioPartners GmbH
      2015   Phase 3   EUCTR2005-000384-26-FR   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2006-002278-24-GB   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-FR   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-ES   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-DE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-CZ   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2005-000346-36-LT   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   Phase 3   EUCTR2005-000384-26-SK   Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2005-000384-26-GB   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-SE   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-DE   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-CZ   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000346-36-SE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-FI   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-DE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
   LG Life Science Ltd.
      2005   -   EUCTR2005-000384-26-ES   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-AT   Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
   LG Life Sciences Ltd.
      2007   Phase 3   EUCTR2006-002278-24-SK   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-AT   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Recombinant human somatotropin   
   University of Milan
      1995   -   NCT00497484   Italy;
Recombinat human growth hormone   
   Versartis, Inc.
      2015   Phase 3   EUCTR2014-004525-41-SE   Belgium;Canada;Netherlands;Poland;Sweden;United States;
Regular insulin   
   Oregon Health and Science University
      2011   -   NCT01804413   United States;
RhGH Norditropin® pen (34 µg/kg)   
   Lumos Pharma
      2020   Phase 2   NCT04614337   Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Routine transdermal oestrogen patch   
   University College, London
      2016   -   NCT02871986   United Kingdom;
SAIZEN   
   Merck KGaA
      2013   Phase 4   EUCTR2012-004263-47-GB   Australia;Czech Republic;Germany;Sweden;United Kingdom;
      2013   Phase 4   EUCTR2012-004263-47-DE   Australia;Czech Republic;Germany;Sweden;United Kingdom;
      2013   -   EUCTR2012-004263-47-SE   Australia;Czech Republic;Germany;Sweden;United Kingdom;
      2013   -   EUCTR2012-004263-47-CZ   Australia;Czech Republic;Germany;Sweden;United Kingdom;
SOMATROPIN (recombinant DNA-derived human growth hormone)   
   Ascendis Pharma Endocrinology Division A/S
      2022   Phase 3   EUCTR2020-000929-42-BG   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-ES   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
SOMATROPIN FOR INJECTION   
   OPKO Biologics Ltd.
      2017   Phase 3   EUCTR2016-003874-42-GR   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-GB   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-ES   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-DE   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-BG   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-003874-42-PL   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-003874-42-FR   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
   Pfizer Inc.
      2019   Phase 3   EUCTR2018-000918-38-SK   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-GB   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-CZ   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-BG   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Saizen   
   Merck KGaA, Darmstadt, Germany
      2005   Phase 4   NCT00256126   Argentina;Australia;Austria;Canada;France;Germany;Italy;Norway;Russian Federation;Singapore;Spain;Sweden;United Kingdom;
   Merck Serono Co., Ltd.
      -   -   EUCTR2015-001569-20-Outside-EU/EEA   China;
   Merck Serono S.A.
      2011   -   EUCTR2010-023430-23-HU   Czech Republic;Hungary;United Kingdom;
      2011   -   EUCTR2010-023430-23-GB   Czech Republic;Hungary;United Kingdom;
      2011   -   EUCTR2010-023430-23-CZ   Czech Republic;Hungary;United Kingdom;
   ModigeneTech Ltd.
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   University Federico II
      2011   -   EUCTR2009-017011-16-SE   Sweden;
Saizen 8mg click.easy powder for solution for injection   
   Merck Serono S.A. Geneva
      2011   -   EUCTR2011-000460-10-CZ   Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
   Merck Serono SA
      2011   -   EUCTR2011-000460-10-GB   Canada;Czech Republic;Italy;Russian Federation;Spain;United Kingdom;
Saizen 8mg click.easy power for solution for injection   
   Merck Serono S.A. Geneva
      2011   Phase 4   EUCTR2011-000460-10-ES   Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Saizen®   
   EMD Serono
      2010   Phase 3   NCT01237340   United States;
Saizen® solution for injection (referred as Saizen®)   
   Merck KGaA
      2013   Phase 4   NCT01806298   Australia;Czech Republic;Germany;Sweden;United Kingdom;
Saline   
   Massachusetts General Hospital
      2004   -   NCT00182091   United States;
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)   
   Centro Medico Teknon
      2004   Phase 2   NCT00497562   Spain;
Sodium Chloride (NaCl) IV   
   Rabin Medical Center
      2020   -   NCT04465565   Israel;
Somapacitan   
   Novo Nordisk A/S
      2022   -   NCT05230550   Japan;
      2021   Phase 3   NCT04970654   China;
      2019   Phase 3   NCT03811535   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 1   NCT03905850   Germany;
      2017   Phase 3   NCT03075644   Japan;
      2017   Phase 1   NCT03212131   Slovakia;
      2017   Phase 1   NCT03186495   Germany;
      2016   Phase 2   NCT02616562   Austria;Belgium;Brazil;France;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   NCT02382939   Denmark;France;Germany;Japan;Sweden;United Kingdom;
      2014   Phase 3   NCT02229851   Australia;Brazil;Germany;India;Israel;Japan;Latvia;Lithuania;Malaysia;Norway;Poland;Romania;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 1   NCT01973244   Austria;Belgium;France;Israel;Macedonia, The Former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2012   Phase 1   NCT01706783   Denmark;Sweden;
      2012   Phase 1   NCT01514500   Germany;
Somapacitan 10 mg/1.5ml PDS290   
   Novo Nordisk A/S
      2020   Phase 3   EUCTR2018-000231-27-PL   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-LV   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-HU   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-ES   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-EE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-SI   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-GB   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DK   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-AT   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-NO   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-IE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-FR   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 10 mg/1.5ml PDS290S   
   NOVO NORDISK. S.P.A.
      2019   Phase 3   EUCTR2018-000231-27-IT   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 15 mg/1.5ml PDS290   
   NOVO NORDISK. S.P.A.
      2019   Phase 3   EUCTR2018-000231-27-IT   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
   Novo Nordisk A/S
      2020   Phase 3   EUCTR2018-000231-27-PL   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-LV   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-HU   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-ES   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-EE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-SI   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-GB   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DK   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-AT   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-NO   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-IE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-FR   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 5 mg/1.5ml PDS290   
   NOVO NORDISK. S.P.A.
      2019   Phase 3   EUCTR2018-000231-27-IT   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
   Novo Nordisk A/S
      2020   Phase 3   EUCTR2018-000231-27-PL   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-LV   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-HU   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-ES   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-000231-27-EE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-SI   Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-GB   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DK   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-DE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000231-27-AT   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-NO   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-IE   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-000231-27-FR   Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somatorelin   
   AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
      2004   -   EUCTR2004-002125-42-IT   Italy;
Somatostatin   
   University of Aarhus
      2009   -   NCT01062529   Denmark;
Somatotropin   
   Federico II University
      2007   Phase 2   NCT01576861   Italy;
      2004   Phase 2   NCT00591760   -
Somatotropine   
   Novo Nordisk Farma Oy
      2009   Phase 4   EUCTR2008-001674-32-FI   Finland;
Somatrogon   
   OPKO Biologics Ltd.
      2017   Phase 3   EUCTR2016-003874-42-GR   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-GB   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-003874-42-ES   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-DE   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2017   Phase 3   EUCTR2016-003874-42-BG   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-003874-42-PL   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-003874-42-FR   Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
   PRM|21097
      2017   Phase 3   EUCTR2016-003874-42-IT   Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
   Pfizer
      2019   Phase 3   NCT03831880   Bulgaria;Czechia;Slovakia;United Kingdom;United States;
   Pfizer Inc.
      2019   Phase 3   EUCTR2018-000918-38-SK   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-GB   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-CZ   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-000918-38-BG   Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Somatrogon (Genetical Recombination)   
   OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
      2017   Phase 3   JPRN-JapicCTI-183963   Japan;
Somatropin   
   ASCENDIS PHARMA A/S
      2010   -   EUCTR2010-021523-28-IT   Austria;Denmark;Germany;Italy;Sweden;
   Altus Pharmaceuticals
      2009   Phase 2   NCT00837863   United States;
   Ascendis Pharma Endocrinology Division A/S
      2020   Phase 3   NCT04615273   Armenia;Australia;Canada;Georgia;Greece;Japan;Poland;Slovakia;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2016-001145-11-DE   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-PL   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-GR   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001145-11-BG   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   BIOPARTNERS GMBH
      2006   -   EUCTR2005-000384-26-IT   Czech Republic;Germany;Italy;Spain;Sweden;United Kingdom;
   Beaufour Ipsen Pharma
      2005   -   EUCTR2004-000356-17-AT   Austria;Denmark;Finland;Italy;
   Beckert Michael
      2021   Phase 3   JPRN-jRCT2051200129   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
   BioPartners GmbH
      2015   Phase 3   EUCTR2005-000384-26-FR   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2006-002278-24-GB   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-FR   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-ES   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-DE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-002278-24-CZ   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2005-000346-36-LT   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   Phase 3   EUCTR2005-000384-26-SK   Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2005-000384-26-GB   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-SE   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-DE   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-CZ   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000346-36-SE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-FI   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
      2005   -   EUCTR2005-000346-36-DE   Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
   Daewoong Pharmaceutical Co. LTD.
      2003   Phase 3   NCT02693522   Korea, Republic of;
   Eli Lilly and Company
      2004   Phase 3   NCT00191165   Italy;
      2003   Phase 3   NCT00191360   Japan;
      1999   Phase 4   NCT00490191   France;Germany;Italy;Puerto Rico;United Kingdom;United States;
      1997   Phase 3   NCT00570011   United States;
   Ferring Pharmaceuticals
      2014   -   NCT02018172   France;
      2013   -   NCT01731028   -
      2007   -   NCT01306357   France;
   Ferring Pharmaceuticals A/S
      2009   -   EUCTR2008-004849-28-HU   Hungary;
   Genentech, Inc.
      2015   Phase 4   NCT02311894   United States;
      2010   -   NCT01243892   United States;
   Genexine, Inc
      2015   Phase 2   EUCTR2014-002698-13-SK   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-SE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-PL   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-HU   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-GR   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
      2015   Phase 2   EUCTR2014-002698-13-DE   France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
   HanAll BioPharma Co., Ltd.
      2011   Phase 1   NCT01440686   Korea, Republic of;
   Ioroi Minoru
      2021   Phase 2   JPRN-jRCT2031210366   Japan;
      2021   Phase 2   JPRN-jRCT2031200372   Japan;
   Ipsen Pharma
      2011   -   EUCTR2010-020742-10-SE   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-GB   Finland;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-020742-10-FI   Finland;Spain;Sweden;United Kingdom;
   Karolinska universitetssjukhuset
      2006   -   EUCTR2005-004478-26-SE   Sweden;
   L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
      2013   Phase 1   NCT01494779   Brazil;
   LG Life Science Ltd.
      2005   -   EUCTR2005-000384-26-ES   Czech Republic;Germany;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2005-000384-26-AT   Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
   LG Life Sciences
      2016   Phase 4   NCT03015909   Korea, Republic of;
   LG Life Sciences Ltd.
      2007   Phase 3   EUCTR2006-002278-24-SK   Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002278-24-AT   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
   Massachusetts General Hospital
      2002   -   NCT00136032   United States;
   Merck Serono S.A. Geneva
      2011   Phase 4   EUCTR2011-000460-10-ES   Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
      2011   -   EUCTR2011-000460-10-CZ   Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
   Merck Serono SA
      2011   -   EUCTR2011-000460-10-GB   Canada;Czech Republic;Italy;Russian Federation;Spain;United Kingdom;
   ModigeneTech Ltd.
      2011   -   EUCTR2010-019374-32-AT   Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SK   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-SI   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      2010   -   EUCTR2010-019374-32-HU   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
      -   -   EUCTR2010-019374-32-DE   Czech Republic;Germany;Hungary;Slovakia;Slovenia;
   NOVO NORDISK. S.P.A.
      2019   Phase 3   EUCTR2018-000231-27-IT   Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
   Novo Nordisk A/S
      2015   Phase 3   NCT02382939   Denmark;France;Germany;Japan;Sweden;United Kingdom;
      2015   Phase 3   EUCTR2014-000290-39-GB   Denmark;European Union;Japan;Sweden;United Kingdom;
      2015   Phase 3   EUCTR2013-002892-16-LV   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2013-002892-16-LT   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-000290-39-DK   Denmark;European Union;Japan;Sweden;United Kingdom;
      2014   Phase 3   NCT02229851   Australia;Brazil;Germany;India;Israel;Japan;Latvia;Lithuania;Malaysia;Norway;Poland;Romania;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002892-16-SE   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-002892-16-GB   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002892-16-DE   Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
      2014   -   EUCTR2014-000290-39-SE   Denmark;European Union;Japan;Sweden;United Kingdom;
      2013   Phase 1   NCT01973244   Austria;Belgium;France;Israel;Macedonia, The Former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
      2009   Phase 2   NCT00936403   Belgium;Czech Republic;Denmark;France;Israel;Macedonia, The Former Yugoslav Republic of;Slovenia;Spain;Turkey;United Kingdom;
      2009   Phase 2   EUCTR2008-008240-25-FR   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   Phase 2   EUCTR2008-008240-25-ES   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   NCT01109017   Japan;
      2009   -   NCT00934063   Germany;
      2009   -   EUCTR2008-008240-25-SI   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-GB   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-DK   Denmark;France;Slovenia;Spain;United Kingdom;
      2009   -   EUCTR2008-008240-25-BE   Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
      2006   -   NCT00960128   Argentina;Belgium;Brazil;Czech Republic;Czechia;Denmark;Finland;Former Serbia and Montenegro;France;Germany;Hungary;Ireland;Israel;Italy;Lithuania;Luxembourg;Netherlands;Norway;Russian Federation;Saudi Arabia;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2005   -   NCT01604161   Japan;
      2004   Phase 3   NCT00184730   Japan;
      2003   Phase 4   NCT00567385   Turkey;
      2003   Phase 3   NCT00519558   Japan;
      2003   Phase 3   NCT00184743   Japan;
      2003   -   NCT01580605   France;
      2003   -   NCT01543880   Germany;
      2002   Phase 3   NCT00184678   Australia;Austria;Belgium;France;Germany;Hungary;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
      2002   -   NCT01009905   United States;
      2001   Phase 4   NCT01698944   Greece;
      2001   Phase 3   NCT01502124   United States;
      2001   -   NCT01543867   Germany;
      2000   Phase 3   NCT01563926   Israel;
      2000   Phase 3   NCT00262249   United States;
      2000   Phase 1   NCT00931476   United States;
      1998   Phase 4   NCT01562834   France;
   OPKO Biologics Ltd.
      2013   -   EUCTR2011-004553-60-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   Phase 2   EUCTR2011-004553-60-HU   Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-SK   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
      2012   -   EUCTR2011-004553-60-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
   OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
      2017   Phase 3   JPRN-JapicCTI-183963   Japan;
   OPKO Health, Inc.
      2016   Phase 3   NCT02968004   Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;Georgia;Germany;Greece;India;Israel;Italy;Korea, Republic of;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2012   Phase 2   NCT01592500   Greece;Hungary;Slovakia;
   PRM|21097
      2017   Phase 3   EUCTR2016-003874-42-IT   Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
   PROLOR Biotech Ltd.
      2012   -   EUCTR2011-004553-60-GR   Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
      2012   -   EUCTR2011-004553-60-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
   Pfizer
      2008   Phase 3   NCT00630487   Germany;
      2007   -   NCT00601419   -
      2005   Phase 3   NCT00163189   France;
      1997   Phase 3   NCT00174278   France;
   Pfizer Pharma GmbH
      2008   -   EUCTR2007-000790-36-DE   Germany;
   Prolor Biotech Ltd
      2010   -   EUCTR2010-019374-32-CZ   Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
   Teva Pharmaceutical Industries, Ltd.
      2014   Phase 2   NCT02092077   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
   The Children's Hospital, Zhejiang University School of Medicine
      2018   -   ChiCTR1800017144   China‘;
   University of Birmingham
      2005   -   EUCTR2004-004835-72-GB   United Kingdom;
   VA Office of Research and Development
      2022   Phase 3   NCT04867317   United States;
Somatropin (INN) recombinant DNA orgin, Escherichia coli   
   Beaufour Ipsen Pharma
      2005   -   EUCTR2004-000356-17-DK   Denmark;Finland;Italy;
Somatropin (rDNA origin)   
   Eli Lilly and Company
      2002   -   NCT01088399   -
Somatropin (recombinant DNA origin produced in E. coli)   
   Ascendis Pharma Endocrinology Division A/S
      2022   Phase 3   EUCTR2020-000929-42-BG   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-IT   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-ES   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Somatropin AQ   
   GeneScience Pharmaceuticals Co., Ltd.
      2010   Phase 1   NCT01613573   -
Somatropin Injection   
   GeneScience Pharmaceuticals Co., Ltd.
      2017   Phase 2   NCT03104010   China;
Somatropin injection   
   Nemours Children's Clinic
      2019   -   NCT04020913   United States;
Somatropina   
   Pfizer, S.A
      2007   Phase 4   EUCTR2007-003586-41-ES   France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Somatropine   
   Sanofi
      2003   Phase 3   NCT00476385   France;
Somavaratan   
   Versartis Inc.
      2017   Phase 3   NCT03145831   Japan;United States;
      2016   Phase 2   NCT02719990   Australia;United States;
      2015   Phase 3   NCT02339090   Belgium;Canada;Netherlands;Poland;Sweden;United States;
      2015   Phase 2   NCT02526420   Australia;Germany;United Kingdom;United States;
      2015   Phase 2   EUCTR2015-002072-24-DE   Australia;Germany;United Kingdom;United States;
      2014   Phase 2/Phase 3   NCT02068521   United States;
   Versartis, Inc.
      2017   Phase 3   EUCTR2016-002780-34-PL   Belgium;Canada;Poland;Sweden;United States;
      2016   Phase 3   EUCTR2016-002780-34-SE   Belgium;Canada;Poland;Sweden;United States;
      2016   Phase 3   EUCTR2016-002780-34-BE   Belgium;Canada;Poland;Sweden;United States;
Somavaratan (VRS-317)   
   Versartis Inc.
      2015   Phase 2/Phase 3   NCT02413138   Japan;
   Versartis, Inc.
      2015   Phase 3   EUCTR2014-004525-41-SE   Belgium;Canada;Netherlands;Poland;Sweden;United States;
Speech pathology evaluation   
   The University of Texas Health Science Center at San Antonio
      1993   -   NCT00227253   United States;
Sterile Water for Injection   
   Ascendis Pharma Endocrinology Division A/S
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Strontium ranelate   
   Royal Liverpool University hospital
      2006   Phase 4   EUCTR2005-004316-73-GB   United Kingdom;
Sustained release growth hormone   
   BIOPARTNERS GMBH
      2007   -   EUCTR2006-002278-24-IT   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Sustained-release recombinant human GH (SR-rhGH)   
   LG Life Sciences
      2009   Phase 4   NCT01605331   -
Synacthen   
   Cardiff University
      2008   Phase 4   EUCTR2007-000056-14-GB   United Kingdom;
   University of Wuerzburg
      2005   -   NCT00552487   Germany;
Synacthen (Tetracosactrin)   
   Cardiff University
      2008   Phase 4   NCT00851942   United Kingdom;
Syntropin   
   Phage Pharmaceuticals, Inc.
      2004   Phase 1   NCT00489294   United States;
TJ101   
   I-Mab Biopharma Co. Ltd.
      2021   Phase 3   NCT04633057   China;
TRANSCON PEG40 HGH   
   Ascendis Pharma Endocrinology Division A/S
      2022   Phase 3   EUCTR2020-000929-42-BG   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-SK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-ES   Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DK   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000929-42-DE   Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003410-20-PL   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-IT   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-BG   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
TRANSCON PEG40 HGH, Transiently PEGylated hGH prodrug   
   Ascendis Pharma Endocrinology Division A/S
      2018   Phase 3   EUCTR2016-001145-11-DE   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-PL   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001145-11-BG   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TV-1106   
   Teva Branded Pharmaceutical Products R&D, Inc.
      2015   Phase 3   NCT02410356   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   NCT02410343   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2013   Phase 2   NCT01811576   Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
   Teva Pharmaceutical Industries Ltd.
      2016   -   EUCTR2014-003796-32-PL   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
      2016   -   EUCTR2014-002736-13-PL   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-SI   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-HR   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-GR   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-DE   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-CZ   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-003796-32-AT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SI   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-SE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HU   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-HR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-GR   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-DE   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-CZ   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2014-002736-13-AT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-SK   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-RO   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-LT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-IT   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-HU   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-ES   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-003796-32-BG   Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-SK   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-LT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-IT   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2015   -   EUCTR2014-002736-13-ES   Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
      2013   Phase 2   EUCTR2012-004975-37-DE   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SK   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-SI   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-SE   Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-HU   Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
      2013   -   EUCTR2012-004975-37-GR   Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
      2013   -   EUCTR2012-004975-37-CZ   Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
   Teva Pharmaceutical Industries, Ltd.
      2015   Phase 2   EUCTR2013-004468-69-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   Phase 2   EUCTR2013-004468-69-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   -   EUCTR2013-004468-69-ES   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   NCT02092077   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-HU   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-GR   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
      -   Phase 2   EUCTR2013-004468-69-RO   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
TV1106   
   Teva Pharmaceutical Industries, Ltd.
      2015   Phase 2   EUCTR2013-004468-69-PL   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   Phase 2   EUCTR2013-004468-69-BG   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2015   -   EUCTR2013-004468-69-ES   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-HU   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-GR   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
      2014   Phase 2   EUCTR2013-004468-69-CZ   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
      -   Phase 2   EUCTR2013-004468-69-RO   Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Tesamorelin   
   Columbia University
      2018   Phase 4   NCT03226821   United States;
Testogel   
   Dr. Chris Thompson
      2006   -   EUCTR2005-005613-38-IE   Ireland;
Testosterone plus somatropin   
   University of Pennsylvania
      2004   Phase 2   NCT00080483   United States;
TheraDerm   
   Massachusetts General Hospital
      2001   -   NCT00027430   United States;
Thyroxin, Triiodothyronine   
   University Hospital Freiburg
      2004   Phase 4   NCT00360074   Germany;
Tiratricol   
   Rare Thyroid Therapeutics International
      2020   Phase 2   EUCTR2019-003370-35-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;United Kingdom;United States;
TransCon hGH   
   Ascendis Pharma A/S
      2017   Phase 3   NCT03344458   Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;New Zealand;Poland;Russian Federation;Ukraine;United States;
   Ascendis Pharma Endocrinology Division A/S
      2017   Phase 3   NCT03305016   Australia;Canada;New Zealand;United States;
   Visen Pharmaceuticals (Shanghai) Co., Ltd.
      2019   Phase 3   NCT04326374   China;
TransCon hGH (ACP-011)   
   Ascendis Pharma Endocrinology Division A/S
      2018   Phase 3   EUCTR2017-003410-20-PL   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-IT   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-GR   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-003410-20-BG   Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-GR   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH (ACP-011) -   
   Ascendis Pharma Endocrinology Division A/S
      2018   Phase 3   EUCTR2016-001145-11-DE   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-PL   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001145-11-BG   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH (ACP-011) - 12,   
   Ascendis Pharma Endocrinology Division A/S
      2017   Phase 3   EUCTR2016-001145-11-GR   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH CT-301 (ACP-011) - 12,   
   Ascendis Pharma Endocrinology Division A/S
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Transdermal Testosterone gel   
   Charles Drew University of Medicine and Science
      2003   Phase 4   NCT00144391   United States;
Transiently PEGylated hGH prodrug   
   Ascendis Pharma A/S
      2013   Phase 2   EUCTR2012-002787-27-SI   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-GR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-DE   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   Phase 2   EUCTR2012-002787-27-CZ   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-HU   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      2013   -   EUCTR2012-002787-27-BG   Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
      -   Phase 2   EUCTR2012-002787-27-FR   Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
   Ascendis Pharma Endocrinology Division A/S
      2017   Phase 3   EUCTR2016-001145-11-IT   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-001145-11-GR   Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Trisequens   
   Dr. Chris Thompson
      2006   -   EUCTR2005-005613-38-IE   Ireland;
VRS-317   
   Versartis Inc.
      2015   Phase 2   EUCTR2015-002072-24-DE   Australia;Germany;United Kingdom;United States;
      2011   Phase 1   NCT01359488   United States;
   Versartis, Inc.
      2017   Phase 3   EUCTR2016-002780-34-PL   Belgium;Canada;Poland;Sweden;United States;
      2016   Phase 3   EUCTR2016-002780-34-SE   Belgium;Canada;Poland;Sweden;United States;
      2016   Phase 3   EUCTR2016-002780-34-BE   Belgium;Canada;Poland;Sweden;United States;
      2016   Phase 3   EUCTR2014-004525-41-PL   Belgium;Canada;Netherlands;Poland;Sweden;United States;
      2015   Phase 3   EUCTR2014-004525-41-BE   Belgium;Canada;Netherlands;Poland;Sweden;United States;
      2015   -   EUCTR2014-004525-41-NL   Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Y-shape pegylated somatropin   
   Xiamen Amoytop Biotech Co., Ltd.
      2018   Phase 2/Phase 3   NCT04513171   China;
ZD1033   
   Nemours Children's Clinic
      -   -   EUCTR2012-001183-30-Outside-EU/EEA   United States;
Zomacton   
   Ferring Pharmaceuticals
      2018   -   NCT03274973   Germany;
      2010   Phase 3   NCT00884000   Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine;
   VU University Medical Center
      2013   -   EUCTR2012-005066-36-NL   Netherlands;
Zomacton 10 mg/ml   
   Ferring Pharmaceuticals A/S
      2009   -   EUCTR2008-004849-28-HU   Hungary;